期刊文献+

HPLC测定环酯红霉素中的3种杂质

Determination of three kinds of impurities in Erythromy cincyclic 11,12-carbonate by HPLC
原文传递
导出
摘要 目的采用HPLC法测定环酯红霉素中的3种杂质。方法色谱柱为Kromasil Eternity-5-C18柱(250 mm×4.6 mm,5μm),流动相为乙腈-0.025 mol·L-1磷酸氢二铵溶液(磷酸先调p H6.2,再用三乙胺调p H7)(50∶50),柱温7℃,流速1.0m L·min^-1,检测波长210 nm。结果环酯红霉素中3种杂质的分离较好,与主峰均能有效分离,线性范围为0.01~0.2 mg·m L^-1(r=0.9999);3种杂质的平均回收率分别为89.2%、99.1%、97.1%,RSD分别为2.62%、2.81%、0.82%。结论所用方法简便、准确、重复性好,可用于环酯红霉素的质量控制。 OBJECTIVE To establish an HPLC method to determine three kinds of impurities in Erythromycin cyclic 11,12-carbonate. METHODS Chromatographic column was Kromasil Eternity-5-C18( 250 mm × 4. 6 mm,5 μm),acetonitrile-0. 025mol·L-1diammonium phosphate( made the p H to 6. 2 with phosphoric acid,and made the p H to 7. 0 with triethylamine)( 50∶50) was mobile phase,The column temperature was 7 ℃ and the flow velocity was 1. 0 mg·m L^-1. The detection wavelength was 210 nm.RESULTS The three kinds of impuritie in Erythromy cincyclic 11,12-carbonate could be effectively separated from the primary and the concentration among 0. 01-0. 2 mg·m L^-1had a linear relationship with the peak area( r both of 0. 9999). The average recoveries were 89. 2%,99. 1%,97. 1%,and the RSD were 2. 62%,2. 81%,0. 82%,respectively. CONCLUSION This method was simple,accurate and reproducible,and could be used for the quality control of Erythromycin cyclic 11,12-carbonate.
出处 《华西药学杂志》 CAS CSCD 2015年第3期368-370,共3页 West China Journal of Pharmaceutical Sciences
关键词 环酯红霉素 高效液相色谱法 杂质 测定 分离 含量 质量控制 Erythromycin cyclic 11 12-carbonate HPLC Impurities Determination Separation Content Qualitycontrol
  • 相关文献

参考文献3

二级参考文献6

  • 1张东红,覃兰辉.女性生殖道支原体、衣原体感染及治疗[J].临床皮肤科杂志,2004,33(8):511-512. 被引量:11
  • 2杨立刚,顾有守,钟山,黎明,张锡宝.克拉霉素治疗男性非淋菌性尿道炎24例[J].临床皮肤科杂志,1996,25(2):96-96. 被引量:36
  • 3Hardy D J, Hensey D M, Beyer J M, et al. Comparative in vitro activities of new 14-, 15-, and 16- membered macrolides [J].Antimicrob Agents Chemother, 1988, 32:1710.
  • 4Bojarska-Dahlig H, Slawinski W, Roslik-Kaminska D, et al. L-Aspartate of erythromycin A cyclic 11, 12-carbonate, a new semisynthetic erythromycin derivative [J]. J Antibiot, 1976,29 : 907.
  • 5Chojnowski W, Zaremba A, Bojarska-Dahlig H. Some biological properties of erythromycin A cyclic carbonate[J]. Acta Polon Pharm,1974,31:241.
  • 6Ferraro M J, Craig W A, Dudley M N, et al. Performance Standards for Antimicrobial Susceptibility Testing [S]. Ninth Informational Supplement. NCCLS, M100-S9,1999,19,1.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部